Articles for the ‘Life Sciences’ Category

The Turkish Medicines and Medical Devices Agency published Guidelines on 29 December 2023 to regulate pharmaceutical exports by entities other than pharmaceutical warehouses, aiming to ensure compliance with national and international standards and safeguard public health. These Guidelines require that only authorized companies can export pharmaceutical products and dietary foods for special medical purposes, necessitating a valid export permit. They outline the process for obtaining export permits, the responsibilities of exporting companies, including their obligation to report any issues with exported products, and the joint liability of the license holder and exporter for the export operations.

Belgium is welcoming a significant development in the field of veterinary medicine law. The Act of 11 July 2023 containing various provisions on health, which entered into force on 8 September 2023, introduces changes across a wide spectrum of healthcare domains, which are encompassed in approximately 20 chapters. In this blog post, we provide an overview of the key changes related to the marketing of veterinary medicines set out in Chapters 4 and 14 of the new Law.

In every jurisdiction the advertising of medical devices comes with certain national peculiarities. The following article explains in more detail what needs to be considered if you intend to market medical devices to the Austrian market

Clyde & Co – UK Life Sciences Sector in Election Year (Jan 2024; rev Feb 24) The next UK general election has to take place before 28 January 2025, current indications are that it could take place in October or November 2024. After 13 years in power, opinion polls suggest that Mr Sunak’s Conservative Party will lose power and be replaced by Sir Keir Starmer KC’s Labour as the governing party.

In this article, Ralph Cox and Nii-Lante Bannerman of Clyde & Co LLP, consider the Conservative Government’s approach to the UK’s life sciences sector over recent years and how that might change under Labour.

This blog post mainly focuses on the CJEU’s findings regarding the responsibility of parallel importers for ensuring the display of the original batch number on the product packaging.